Glycogen synthase kinase-3 (GSK-3), which phosphorylates and inactivates glycogen synthase, is elevated in insulin resistant states including individuals with type 2 diabetes independent of obesity [9] and in animal models [10]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.